Medicare Enrolled
Dr. Winfried Waider, MD
Cardiovascular Disease · Long Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Waider from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waider?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Waider
Dr. Winfried Waider is a cardiovascular disease specialist in Long Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Waider performed 7,520 Medicare services across 2,706 unique beneficiaries.
Between the years covered by Open Payments, Dr. Waider received a total of $14,852 from 47 pharmaceutical and/or device companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Waider is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in CA
$14,852 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,520
Medicare services
Top 10% in CA for cardiovascular disease
2,706
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~396 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
2,107 | $42 | $114 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,446 | $44 | $147 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,198 | $102 | $225 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
557 | $70 | $108 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
401 | $7 | $60 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
284 | $41 | $111 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
245 | $100 | $216 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
196 | $12 | $36 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
122 | $53 | $135 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
110 | $180 | $569 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
104 | $139 | $419 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 92 | $416 | $2,082 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
87 | $165 | $489 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
79 | $63 | $163 |
| New patient office visit, complex (60-74 min) | 67 | $168 | $429 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
60 | $72 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
52 | $18 | $46 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
52 | $12 | $31 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
48 | $1,737 | $4,400 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
48 | $124 | $314 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
31 | $399 | $1,057 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
26 | $61 | $196 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
25 | $10 | $250 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
25 | $18 | $44 |
| Cardiac catheterization | 21 | $195 | $610 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
19 | $12 | $263 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
18 | $69 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
8.3% medium
90.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,852
Total received (2018-2024)
Avg $2,122/year across 7 years
Top 21% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
635
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,654 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,522
2023
$1,817
2022
$1,983
2021
$1,336
2020
$1,393
2019
$2,054
2018
$4,747
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$244
PFIZER INC.
$233
Janssen Pharmaceuticals, Inc
$183
AstraZeneca Pharmaceuticals LP
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$170
E.R. Squibb & Sons, L.L.C.
$106
Amgen Inc.
$76
Kiniksa Pharmaceuticals International, plc
$68
SANOFI-AVENTIS U.S. LLC
$56
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$55
CARDIVA MEDICAL, INC.
$48
Merck Sharp & Dohme LLC
$27
CVRx, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
SCPHARMACEUTICALS INC.
$22
Kestra Medical Technology Services, Inc.
$14
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$2,270
Janssen Pharmaceuticals, Inc
$2,024
Novartis Pharmaceuticals Corporation
$1,577
PFIZER INC.
$1,162
Amgen Inc.
$1,124
SANOFI-AVENTIS U.S. LLC
$721
AstraZeneca Pharmaceuticals LP
$703
E.R. Squibb & Sons, L.L.C.
$626
Boston Scientific Corporation
$532
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$519
Boehringer Ingelheim Pharmaceuticals, Inc.
$424
Gilead Sciences, Inc.
$319
Esperion Therapeutics, Inc.
$250
Abbott Laboratories
$219
Regeneron Healthcare Solutions, Inc.
$209
Astellas Pharma US Inc
$198
Actelion Pharmaceuticals US, Inc.
$180
Kiniksa Pharmaceuticals, Ltd.
$167
Merck Sharp & Dohme LLC
$142
CARDIVA MEDICAL, INC.
$137
Medtronic, Inc.
$136
CVRx, Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$100
ARBOR PHARMACEUTICALS, INC.
$86
Impulse Dynamics (USA) Inc.
$79
Kestra Medical Technology Services, Inc.
$77
Amarin Pharma Inc.
$71
Kiniksa Pharmaceuticals International, plc
$68
Allergan Inc.
$62
Merck Sharp & Dohme Corporation
$62
Invuity, Inc.
$45
BIOTRONIK INC.
$40
ABIOMED
$39
Corindus Inc.
$36
Novo Nordisk Inc
$36
SCPHARMACEUTICALS INC.
$35
Philips Electronics North America Corporation
$35
Lantheus Medical Imaging, Inc.
$31
Baxter Healthcare
$30
Arbor Pharmaceuticals, Inc.
$29
Chiesi USA, Inc.
$27
GENZYME CORPORATION
$23
PORTOLA PHARMACEUTICALS, INC.
$23
Biom'Up France SAS
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
Cardiovascular Systems Inc.
$21
iRhythm Technologies, Inc.
$13
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · Adempas · Arcalyst · Assure WCD · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · Cardiva VASCADE MVP VVCS 6-12F · CorPath GRX · Corlanor · Coronary Orbital Atherectomy System · DEFINITY · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · FABRY-DISEASE · FARXIGA · FUROSCIX · HemoBlast Bellows · Hillrom - Cardiac Ambulatory Monitor · IGT Device Undivided · Impella · JARDIANCE · KENGREAL · Kerendia · LATITUDE · LEQVIO · Letairis · LifeVest · MICRA · MITRACLIP · MOMENTUM · MULTAQ · NEXLETOL · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Photonblade · REVEAL LINQ · ROTABLATOR · Repatha · Resolute · Reveal LINQ · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · WATCHMAN Access System · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
613
Per 100K population
6.2
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Waider is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Waider experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Waider performed 2,107 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waider receive payments from pharmaceutical companies?
Yes. Dr. Waider received a total of $14,852 from 47 companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waider's costs compare to other cardiologists in Long Beach?
Dr. Waider's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waider) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Long Beach
Browse cardiologists in Long Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology